Omkar Speciality Chemicals Faces Zero Revenue, Ongoing Losses Post-CIRP Approval

Omkar Speciality Chemicals has reported zero revenue from operations for the first three quarters of the financial year ending March 2026. The company also posted net losses across these periods, totaling ₹-1.2562 crore for the nine months ended December 31, 2025.

Reader Takeaway: Operational revival is key amid zero revenue and ongoing losses, with auditors flagging going concern issues.

What Just Happened

Omkar Speciality Chemicals announced its unaudited financial results for the quarters ending June 30, 2025, September 30, 2025, and December 31, 2025. The company recorded zero revenue from operations in all three periods. Net losses were reported at ₹-0.4098 crore for the June quarter, ₹-0.5179 crore for the September quarter, and ₹-0.3284 crore for the December quarter. For the nine months ending December 31, 2025, the total loss stood at ₹-1.2562 crore.

The company is now under new management and a Monitoring Committee following the National Company Law Tribunal's (NCLT) approval of its Resolution Plan on July 31, 2025. Key management appointments include Mr. Dipak Kumar Shaw as CEO and Mr. Ruhini Kumar Chakraborty as an Independent Director. The Audit and Stakeholder's Relationship Committees have been reconstituted, and new Statutory and Secretarial Auditors appointed.

Why This Matters

The financial results underscore the significant challenges Omkar Speciality Chemicals faces in its post-insolvency and resolution process. Zero revenue indicates that core business operations have not yet resumed, and continued losses highlight the immediate need for capital infusion and strategic revival plans. The qualified conclusion from the statutory auditors regarding the 'going concern' assumption is a critical red flag for investors, signalling potential doubts about the company's ability to continue operating in the near future despite the resolution plan's approval.

The Backstory

Omkar Speciality Chemicals underwent the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code (IBC). The NCLT's approval of a resolution plan on July 31, 2025, marked the formal conclusion of this process and the handover to a new board. The company's paid-up equity capital as of September 30, 2025, was ₹20.578 crore. The total resolution amount approved was ₹26.65 crore.

What Changes Now

The company is transitioning to a new operational phase under its reconstituted board and management. The focus will be on reviving business activities, utilizing the resolution amount for expansion and working capital, and addressing the concerns raised by the auditors. The appointment of new leadership and auditors is aimed at establishing better governance and operational oversight.

Risks to Watch

• Auditor Qualification: The 'Qualified Conclusion' from statutory auditors on the going concern assumption is a major risk. This suggests underlying financial instability or uncertainties that need to be resolved.
• Zero Revenue: The continued absence of revenue from operations points to significant operational inactivity. A successful revival of the core chemical business is paramount.
• Financial Uncertainty: A negative net worth, as indicated by the assets and liabilities statement, signifies a precarious financial position that requires successful turnaround strategies and potential further capital infusion.

Peer Comparison

While Omkar Speciality Chemicals navigates its revival, its peers in the specialty chemicals sector are generally focused on growth and expanding market share. Companies like Aarti Industries, Vinati Organics, and Deepak Nitrite, among others, have reported strong revenue growth and profitability in recent periods, driven by demand in end-user industries. Omkar's current situation of zero revenue and ongoing losses starkly contrasts with the performance of its healthier counterparts.

Context Metrics

• Loss for 9 months ended Dec 31, 2025: ₹-1.2562 crore
• Total Resolution Amount: ₹26.65 crore
• Paid-up Equity Capital as of Sept 30, 2025: ₹20.578 crore

What to Track Next

Investors will be keenly watching for any signs of operational turnaround, such as the resumption of revenue generation and order book development. Performance of the new management team, clarity on the going concern issue from auditors, and the successful deployment of the resolution amount for business revival will be critical indicators for the company's future prospects.